RTTNews | Aug 5, 2021 06:37AM EDT

06:37 Thursday, August 5, 2021 (RTTNews.com) - Regeneron Pharmaceuticals (REGN) revealed a profit for its second quarter that advanced from the same period last year.

The company's earnings totaled $3.10 billion, or $27.97 per share. This compares with $0.90 billion, or $7.61 per share, in last year's second quarter.

Excluding items, Regeneron Pharmaceuticals reported adjusted earnings of $2.90 billion or $25.80 per share for the period.

Analysts had expected the company to earn $17.69 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 163.6% to $5.14 billion from $1.95 billion last year.

Regeneron Pharmaceuticals earnings at a glance:

-Earnings (Q2): $2.90 Bln. vs. $0.85 Bln. last year.-EPS (Q2): $25.80 vs. $7.16 last year.-Analysts Estimate: $17.69-Revenue (Q2): $5.14 Bln vs. $1.95 Bln last year.

Read the original article on RTTNews ( https://www.rttnews.com/3216330/regeneron-pharmaceuticals-q2-adjusted-earnings-beat-estimates.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved